Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$148,664,149
+$5,511,835 QoQ
Shares Held
2,580,079
+9.3% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#83
of 2,514 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 52%
None 48%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. BMY ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in BMY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,664,149 | 2,580,079 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $143,152,314 | 2,360,302 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $166,333,373 | 3,083,674 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $85,480,599 | 1,895,357 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $95,806,318 | 2,069,698 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $73,354,745 | 1,202,734 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $148,470,507 | 2,625,009 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $129,698,778 | 2,506,741 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $35,325,416 | 850,600 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $39,406,879 | 726,662 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $145,078,972 | 2,827,499 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $87,124,539 | 1,501,112 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $84,260,199 | 1,317,595 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $64,735,955 | 934,006 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $80,724,013 | 1,121,946 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $21,157,947 | 297,622 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $28,692,356 | 372,628 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $17,891,473 | 244,988 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $23,083,528 | 370,225 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||